QuidelOrtho Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
QuidelOrtho Corporation income statement - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2025Dec 2024Dec 2023Jan 2023Jan 2022Jan 2021Dec 2019Dec 2018
Revenue & Gross Profit
Revenue2.732.783.003.271.701.660.530.52
Cost of Revenue1.461.501.501.330.420.310.210.21
Gross Profit1.271.291.501.941.281.360.320.32
Operating Expenses
Research & Development0.190.220.250.190.100.080.050.05
Selling, General & Administrative0.750.770.760.620.240.180.160.15
Operating Expenses2.191.241.210.940.360.290.220.21
Operating Income-0.920.050.280.990.921.060.100.11
Other Income/Expense
Interest Income0.000.000.010.000.000.000.000.00
Interest Expense0.180.19-0.18-0.080.000.000.010.02
Other Income/Expense-0.19-1.990.01-0.01-0.01-0.01-0.01-0.02
Income
Income Before Tax-1.11-2.13-0.030.740.901.040.080.06
Income Tax Expense0.02-0.08-0.020.190.200.230.00-0.01
Net Income-1.13-2.05-0.010.550.700.810.070.07
Net Income - Continuous Operations-1.13-2.05-0.010.550.700.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.000.00
EBITDA-0.49-1.490.741.280.971.110.140.13
EBIT0.00-1.940.280.990.921.060.090.09
Depreciation & Amortization0.440.200.460.280.050.050.000.00
Earnings Per Share
Basic EPS-17.00-30.00-10.0017.0019.002.002.00
Diluted EPS-17.00-30.00-10.0016.0019.002.002.00
Basic Shares Outstanding0.070.070.070.060.040.040.040.04
Diluted Shares Outstanding0.070.070.070.060.040.040.040.04